We are live on ! Find out more
WST icon

West Pharmaceutical

302 hedge funds and large institutions have $6.72B invested in West Pharmaceutical in 2017 Q3 according to their latest regulatory filings, with 37 funds opening new positions, 118 increasing their positions, 96 reducing their positions, and 41 closing their positions.

New
Increased
Maintained
Reduced
Closed

2,006% more call options, than puts

Call options by funds: $1.01M | Put options by funds: $48K

23% more repeat investments, than reductions

Existing positions increased: 118 | Existing positions reduced: 96

6% more capital invested

Capital invested by funds: $6.36B → $6.72B (+$352M)

2.76% more ownership

Funds ownership: 91.55%94.31% (+2.8%)

0% more funds holding in top 10

Funds holding in top 10: 22 (0)

10% less first-time investments, than exits

New positions opened: 37 | Existing positions closed: 41

2% less funds holding

Funds holding: 309302 (-7)

Holders
302
Holders Change
-7
Holders Change %
-2.27%
% of All Funds
7.53%
Holding in Top 10
2
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
0.05%
New
37
Increased
118
Reduced
96
Closed
41
Calls
$1.01M
Puts
$48K
Net Calls
+$963K
Net Calls Change
+$170K
Name Holding Trade Value Shares
Change
Change in
Stake
OPERF
126
Oregon Public Employees Retirement Fund
Oregon
$2.61M +$35.6K +394 +1%
SEI Investments
127
SEI Investments
Pennsylvania
$2.58M +$2.33M +25,805 +2,696%
Mawer Investment Management
128
Mawer Investment Management
Alberta, Canada
$2.53M +$2.38M +26,285 New
CCA
129
Conestoga Capital Advisors
Pennsylvania
$2.5M +$1.29M +14,218 +121%
BNP Paribas Financial Markets
130
BNP Paribas Financial Markets
France
$2.32M -$448K -4,946 -17%
WT
131
Whittier Trust
California
$2.3M +$30.6K +338 +1%
RA
132
Royce & Associates
New York
$2.21M
MERSOM
133
Municipal Employees' Retirement System of Michigan
Michigan
$2.15M -$544K -6,010 -21%
AAM
134
Advisors Asset Management
Colorado
$2.15M -$839K -9,275 -29%
Stifel Financial
135
Stifel Financial
Missouri
$2.14M +$185K +2,047 +10%
D.E. Shaw & Co
136
D.E. Shaw & Co
New York
$2.14M -$9.84M -108,728 -83%
AIM
137
Assured Investment Management
New York
$2.1M -$593K -6,556 -23%
BG
138
Bahl & Gaynor
Ohio
$2.06M -$76.9K -850 -4%
B
139
Barings
North Carolina
$2.03M
VRS
140
Virginia Retirement Systems
Virginia
$1.99M -$1.02M -11,300 -35%
Russell Investments Group
141
Russell Investments Group
United Kingdom
$1.97M +$586K +6,472 +46%
BC
142
Brinker Capital
Pennsylvania
$1.92M +$169K +1,872 +10%
AIP
143
Ameritas Investment Partners
Nebraska
$1.92M
GIA
144
GHP Investment Advisors
Colorado
$1.91M -$1.89M -20,937 -51%
LSERS
145
Louisiana State Employees Retirement System
Louisiana
$1.91M +$54.3K +600 +3%
LMGAM
146
Liberty Mutual Group Asset Management
Massachusetts
$1.85M -$844K -9,324 -33%
DCM
147
Dynamic Capital Management
Jersey
$1.74M -$771K -8,517 -32%
CCG
148
Chatham Capital Group
Georgia
$1.67M
TRSOTSOK
149
Teachers Retirement System of the State of Kentucky
Kentucky
$1.63M
SAA
150
Southeast Asset Advisors
Georgia
$1.6M +$172K +1,900 +13%

WST Hedge Fund Activity: Q3 2017 in Review

302 of the 4,011 institutional investors tracked by Wall St. Rank reported a position in West Pharmaceutical (WST) for Q3 2017, worth a combined $6.72B — up 5.5% from $6.36B a quarter earlier.

Sellers outnumbered buyers: 41 funds closed out of WST and 37 opened new positions — a net loss of 4 holders — while 96 trimmed existing stakes and 118 added.

The largest buyer was William Blair Investment Management, opening a new position worth an estimated $80.4M. The largest seller was Millennium Management, cutting an estimated $65.5M.

  • 302 institutional investors held West Pharmaceutical (WST) as of Q3 2017, down from 309 in Q2 2017.
  • Funds reported $6.72B of West Pharmaceutical stock for Q3 2017, up 5.5% quarter-over-quarter.
  • 37 funds opened new West Pharmaceutical positions in Q3 2017 and 41 closed out, a net change of -4 holders.
  • The largest West Pharmaceutical buyer in Q3 2017 was William Blair Investment Management, an estimated $80.4M added.
  • The largest West Pharmaceutical seller in Q3 2017 was Millennium Management, an estimated $65.5M sold.

Based on aggregated 13F filings for Q3 2017.